HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical evaluation of a bleomycin-group antitumor antibiotic bleomycetin].

Abstract
The efficacy of bleomycetin or bleomycin A5 was studied in 128 patients with different malignant neoplasms. The antibiotic was used as a systemic or intracavitary chemotherapeutic agent. Bleomycetin was effective in 75-80, 81.8, 58.3, 70 and 50 per cent of the cases with disseminated derminogenic tumor of the testicle, squamous cell carcinoma of the head and neck, cancer of the penis, carcinoma of the skin and lymphogranulomatosis, respectively. When used intracavitarily the drug was effective in 41.2 per cent of the patients with cancer of the ovaries and lungs, teratoblastoma of the ovaries, cancer of the mammary gland and sarcoma of the soft tissues. Hyperthermia and focal hyperkeratosis as the adverse reactions were observed in 40.6 and 5.4 per cent of the patients, respectively. No toxicity with respect to the lungs was registered.
AuthorsL V Manziuk, N I Perevodchikova
JournalAntibiotiki (Antibiotiki) Vol. 27 Issue 5 Pg. 372-7 (May 1982) ISSN: 0003-5637 [Print] Russia (Federation)
Vernacular TitleKlinicheskaia otsenka protivo-opukholevogo antibiotika iz gruppy bleomitsinov-bleomitsetina.
PMID6179464 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Bleomycin
  • bleomycetin
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibiotics, Antineoplastic (administration & dosage, adverse effects, therapeutic use)
  • Bleomycin (administration & dosage, adverse effects, therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms (drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: